Limitations of endoscopic ablation in Barrett's esophagus

Avyakta Kallam, Benjamin R. Alsop, Prateek Sharma

Research output: Contribution to journalReview article

Abstract

In the last 5-10 years, endoscopic ablative therapies have been gaining ground as treatment for Barrett's esophagus associated with high-grade dysplasia and early cancer, and they are becoming the most preferred technique over surgery as the standard of care. These therapies are associated with a lower rate of complications and mortality than surgery; studies have found them to be safe, effective and tolerable. Endoscopic ablative therapies are not, however, without their drawbacks. There is a paucity of data on long-term efficacy, and direct comparisons of the different modalities are lacking. Unlike surgery, current data suggest that endoscopic ablation treatments may not be curative in all patients, so patients require ongoing surveillance and acid suppression. Questions remain regarding durability as well as factors promoting recurrence after endoscopic therapy. The authors conducted a systematic review of the literature on ablative therapies in Barrett's esophagus to describe the modalities currently available and to provide an understanding of their limitations.

Original languageEnglish (US)
Pages (from-to)487-496
Number of pages10
JournalExpert Review of Gastroenterology and Hepatology
Volume9
Issue number4
DOIs
StatePublished - Apr 1 2015

Fingerprint

Barrett Esophagus
Therapeutics
Standard of Care
Recurrence
Acids
Mortality
Neoplasms

Keywords

  • Ablation therapies
  • Barrett's esophagus
  • Cryoablation
  • Limitations of ablation therapy
  • Photodynamic therapy
  • Radiofrequency ablation
  • Recurrences in ablation therapy

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Limitations of endoscopic ablation in Barrett's esophagus. / Kallam, Avyakta; Alsop, Benjamin R.; Sharma, Prateek.

In: Expert Review of Gastroenterology and Hepatology, Vol. 9, No. 4, 01.04.2015, p. 487-496.

Research output: Contribution to journalReview article

Kallam, Avyakta ; Alsop, Benjamin R. ; Sharma, Prateek. / Limitations of endoscopic ablation in Barrett's esophagus. In: Expert Review of Gastroenterology and Hepatology. 2015 ; Vol. 9, No. 4. pp. 487-496.
@article{06b33509fedf4fd09d3da94154f06b1c,
title = "Limitations of endoscopic ablation in Barrett's esophagus",
abstract = "In the last 5-10 years, endoscopic ablative therapies have been gaining ground as treatment for Barrett's esophagus associated with high-grade dysplasia and early cancer, and they are becoming the most preferred technique over surgery as the standard of care. These therapies are associated with a lower rate of complications and mortality than surgery; studies have found them to be safe, effective and tolerable. Endoscopic ablative therapies are not, however, without their drawbacks. There is a paucity of data on long-term efficacy, and direct comparisons of the different modalities are lacking. Unlike surgery, current data suggest that endoscopic ablation treatments may not be curative in all patients, so patients require ongoing surveillance and acid suppression. Questions remain regarding durability as well as factors promoting recurrence after endoscopic therapy. The authors conducted a systematic review of the literature on ablative therapies in Barrett's esophagus to describe the modalities currently available and to provide an understanding of their limitations.",
keywords = "Ablation therapies, Barrett's esophagus, Cryoablation, Limitations of ablation therapy, Photodynamic therapy, Radiofrequency ablation, Recurrences in ablation therapy",
author = "Avyakta Kallam and Alsop, {Benjamin R.} and Prateek Sharma",
year = "2015",
month = "4",
day = "1",
doi = "10.1586/17474124.2015.976554",
language = "English (US)",
volume = "9",
pages = "487--496",
journal = "Expert Review of Gastroenterology and Hepatology",
issn = "1747-4124",
publisher = "Expert Reviews Ltd.",
number = "4",

}

TY - JOUR

T1 - Limitations of endoscopic ablation in Barrett's esophagus

AU - Kallam, Avyakta

AU - Alsop, Benjamin R.

AU - Sharma, Prateek

PY - 2015/4/1

Y1 - 2015/4/1

N2 - In the last 5-10 years, endoscopic ablative therapies have been gaining ground as treatment for Barrett's esophagus associated with high-grade dysplasia and early cancer, and they are becoming the most preferred technique over surgery as the standard of care. These therapies are associated with a lower rate of complications and mortality than surgery; studies have found them to be safe, effective and tolerable. Endoscopic ablative therapies are not, however, without their drawbacks. There is a paucity of data on long-term efficacy, and direct comparisons of the different modalities are lacking. Unlike surgery, current data suggest that endoscopic ablation treatments may not be curative in all patients, so patients require ongoing surveillance and acid suppression. Questions remain regarding durability as well as factors promoting recurrence after endoscopic therapy. The authors conducted a systematic review of the literature on ablative therapies in Barrett's esophagus to describe the modalities currently available and to provide an understanding of their limitations.

AB - In the last 5-10 years, endoscopic ablative therapies have been gaining ground as treatment for Barrett's esophagus associated with high-grade dysplasia and early cancer, and they are becoming the most preferred technique over surgery as the standard of care. These therapies are associated with a lower rate of complications and mortality than surgery; studies have found them to be safe, effective and tolerable. Endoscopic ablative therapies are not, however, without their drawbacks. There is a paucity of data on long-term efficacy, and direct comparisons of the different modalities are lacking. Unlike surgery, current data suggest that endoscopic ablation treatments may not be curative in all patients, so patients require ongoing surveillance and acid suppression. Questions remain regarding durability as well as factors promoting recurrence after endoscopic therapy. The authors conducted a systematic review of the literature on ablative therapies in Barrett's esophagus to describe the modalities currently available and to provide an understanding of their limitations.

KW - Ablation therapies

KW - Barrett's esophagus

KW - Cryoablation

KW - Limitations of ablation therapy

KW - Photodynamic therapy

KW - Radiofrequency ablation

KW - Recurrences in ablation therapy

UR - http://www.scopus.com/inward/record.url?scp=84924423859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924423859&partnerID=8YFLogxK

U2 - 10.1586/17474124.2015.976554

DO - 10.1586/17474124.2015.976554

M3 - Review article

C2 - 25483982

AN - SCOPUS:84924423859

VL - 9

SP - 487

EP - 496

JO - Expert Review of Gastroenterology and Hepatology

JF - Expert Review of Gastroenterology and Hepatology

SN - 1747-4124

IS - 4

ER -